Dataset Information


SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms.

ABSTRACT: Recurrent gene mutations have been described with varying frequencies in myelodysplasia (MDS) /myeloproliferative neoplasm (MPN) overlap syndromes (MMOS). Recent work has placed significant focus on understanding the role of gene lesions involving the spliceosomal machinery in leukemogeneis. SRSF2 is a gene encoding critical spliceosomal proteins. SRSF2 mutations appear to play an important role in pathogenesis of MMOS, particularly in chronic myelomonocytic leukemia. Inhibition of splicing may be a new therapeutic approach. E7107, a spliceosome inhibitor, has been shown to differentially inhibit splicing more in SRSF2-mutant cells leading to decreased leukemia burden in mice. H3B-8800 is a small molecule modulator of spliceosome complex and has been shown to lower leukemia burden in SRSF2-P95H mutant mice. This review focuses on the incidence of mutant SRSF2 across various MMOS as well as recent clinical development of spliceosome inhibitors.

PROVIDER: S-EPMC6158887 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| E-GEOD-74064 | BioStudies
| S-EPMC4899191 | BioStudies
2016-03-31 | E-GEOD-74064 | ArrayExpress
| E-GEOD-71299 | BioStudies
| S-EPMC4553800 | BioStudies
| S-EPMC6730556 | BioStudies
2017-12-20 | GSE94999 | GEO
2015-08-10 | E-GEOD-71299 | ArrayExpress
| E-GEOD-65349 | BioStudies
| S-EPMC4429920 | BioStudies